News Image

Top movers in Thursday's session

By Mill Chart

Last update: Sep 29, 2022

Let's have a look at what is happening on the US markets in the middle of the day on Thursday. Below you can find the top gainers and losers in today's session.

Gainers

TickerChangeComment
SNTI47.14%SENTI BIOSCIENCES INC's (NASDAQ:SNTI) stock price is advancing with 47.14% to a price of $2.06. In the last month the stock lost 27.08%.
BBAI38.31%BIGBEAR.AI HOLDINGS INC's (NYSE:BBAI) shares rose 38.31% to $1.65 during Thursday's session. A press release (BigBear.ai Awarded $14.8 Million U.S. Army Global Force Information Management System Contract) was released earlier today.
BEAT30.52%HEARTBEAM INC's (NASDAQ:BEAT) shares rose 30.52% to $4.49. Earlier today the company had a press release: HeartBeam to Present at Upcoming Investor Conferences.
TBLTW23.11%TOUGHBUILT INDUSTRIES-CW23's (NASDAQ:TBLTW) stock price increased by 23.11% to $0.14. Shareholders saw the stock price going 36.02% lower in the past month.
JUPW23.01%JUPITER WELLNESS INC's (NASDAQ:JUPW) shares rose 23.01% to $0.75. In the last month the share price dropped with 21.68%.
SSNT22.58%SILVERSUN TECHNOLOGIES INC's (NASDAQ:SSNT) stock price is advancing with 22.58% to a price of $3.04. A press release (SSNT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of SilverSun Technologies, Inc. Is Fair to Shareholders) was released earlier today.
ADTX22.22%ADITXT INC's (NASDAQ:ADTX) shares rose 22.22% to $3.74. In the last month the share price dropped with 60.26%.
GSUN20.67%GOLDEN SUN EDUCATION GROUP-A's (NASDAQ:GSUN) stock price increased by 20.67% to $34.38. The stock is trading 68.08% higher than 3 months ago.
CGTX20.11%COGNITION THERAPEUTICS INC's (NASDAQ:CGTX) shares rose 20.11% to $2.09 during Thursday's session. Earlier today the company had a press release: Cognition Therapeutics to Participate in the 2022 Cantor Fitzgerald Neurology & Psychiatry Conference.
IMVT18.68%IMMUNOVANT INC's (NASDAQ:IMVT) shares rose 18.68% to $5.68. In the last 3 months the stock gained 20.35%.

For the full top gainers list go to our top gainers screener.

Top losers

TickerChangeComment
SUNL-58.13%SUNLIGHT FINANCIAL HOLDINGS's (NYSE:SUNL) shares fell 58.13% to $1.05 during Thursday's session. A press release (Sunlight Financial Announces Impact to Full-Year 2022 Outlook) was released yesterday.
ADVWW-47.62%ADVANTAGE SOLUTIONS IN-CW25's (NASDAQ:ADVWW) shares fell 47.62% to $0.11. In the last month the stock lost 52.28%.
LGHL-39.7%LION GROUP HOLDING LTD-S ADR's (NASDAQ:LGHL) stock price is declining with 39.7% to a price of $1.2. In the last 3 months the share price increased with 125.0%.
SOBR-29.15%SOBR SAFE INC's (NASDAQ:SOBR) stock price decreased by 29.15% to $1.75. Earlier today the company had a press release: SOBR Safe Technology Is Doing More Than Generating Revenues And Creating Shareholder Value; It’s Saving Lives ($SOBR).
VEEE-28.17%TWIN VEE POWERCATS CO's (NASDAQ:VEEE) shares fell 28.17% to $2.55. The stock is trading 22.32% lower than a month ago.
RAD-26.24%RITE AID CORP's (NYSE:RAD) stock price is declining with 26.24% to a price of $5.18. RITE AID CORP released earnings Yesterday. A press release (Rite Aid Corporation Reports Fiscal 2023 Second Quarter Results) was released earlier today.
ISR-26.17%ISORAY INC's (NYSEARCA:ISR) shares fell 26.17% to $0.22. Earlier today the company had a press release: ISR Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Isoray, Inc. Is Fair to Shareholders.
PHAS-25.21%PHASEBIO PHARMACEUTICALS INC's (NASDAQ:PHAS) shares fell 25.21% to $0.19 during Thursday's session. In the last month the share price dropped with 75.29%.
KMX-23.8%CARMAX INC's (NYSE:KMX) shares fell 23.8% to $65.85 during Thursday's session. CARMAX INC released earnings Yesterday. A press release (CarMax Reports Second Quarter Fiscal 2023 Results) was released earlier today.
AMPS-22.7%ALTUS POWER INC's (NYSE:AMPS) stock price decreased by 22.7% to $11.0. A press release (Altus Power, Inc. Announces Pricing of Secondary Underwritten Public Offering of Class A Common Stock) was released yesterday.

To see the full list of top losers you can use our top losers screener.

Back

SENTI BIOSCIENCES INC

NASDAQ:SNTI (4/24/2024, 7:00:03 PM)

After market: 0.2879 +0.01 (+2.49%)

0.2809

-0.02 (-6.37%)

SNTI News

News Imagea month ago - InvestorPlaceSNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023

SNTI stock results show that Senti Biosciences missed analyst estimates for earnings per share the fourth quarter of 2023.

News Imagea month ago - BusinessInsiderSNTI Stock Earnings: Senti Biosciences Misses EPS for Q4 2023

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Senti Biosciences (NASDAQ:SNTI) just reported results for the fourth quarter of...

News Imagea month ago - Senti Biosciences, Inc.Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights
News Imagea month ago - Senti Biosciences, Inc.Senti Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Reviews Recent Highlights

– IND for SENTI-202, a potential first-in-class logic-gated treatment for AML, cleared by the U.S. FDA; First patient dosing anticipated in the second...

News Image4 months ago - Seeking AlphaSenti Biosciences to reduce workforce by 37% (NASDAQ:SNTI)

Senti Biosciences plans to cut workforce by ~37% to prioritize investment in its cell therapy for acute myeloid leukemia, SENTI-202.

News Image4 months ago - Senti Biosciences, Inc.Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program
News Image4 months ago - Senti Biosciences, Inc.Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program

– Strategic resource allocation to focus investment on clinical development of SENTI-202 and SENTI-301A partnership in China; interim data from Phase 1...

News Image4 months ago - Senti Biosciences, Inc.Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
News Image4 months ago - Senti Biosciences, Inc.Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia

– First patient in Phase 1 clinical trial expected to be treated in Q2 2024 – – Initial clinical efficacy data expected by year-end 2024 and durability...

News Image4 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Checking out the biggest pre-market stock movers for Tuesday is the perfect way to get ready for another busy day of trading!

News Image5 months ago - InvestorPlaceToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

It's time to start the day with a breakdown of the biggest pre-market stock movers worth keeping an eye on for Thursday!

SNTI Links
Follow us for more